Anti-Slavery and Human Trafficking Statement

  1. Introduction

2Encapsulate Limited (“2Encapsulate”, “the Company”, “we”, “us” or “our”) is committed to taking steps to prevent slavery, servitude, forced or compulsory labor and all other human trafficking-related activities (together, “Modern Slavery”) in our business and supply chain. We have zero tolerance towards all forms of Modern Slavery and require our supply chain to align with our values.

This Anti-Slavery and Human Trafficking Statement (the “Statement”) is prepared in accordance with Section 54(1), Part 6 of the Modern Slavery Act 2015 and relates to actions and activities taken by 2Encapsulate for the financial year ended 2025/6.

  1. Organizational Structure and Supply Chains

2Encapsulate mainly operates in the UK. We operate in the chemical remediation and formulated product sectors, and the nature of our supply chain is as follows: we work with direct suppliers that provide us with goods such as equipment for our premises and services such as outsourced business processes, IT and software. We also have strategic partners and clients.

For more information about our group of companies, please visit www.2Encapsulate.com.

2Encapsulate holds itself to a high standard of ethical conduct, as addressed in its Business Conduct Statement, and we require the same level of conduct from all of our suppliers, as mentioned above through the Supplier Compliance Policy. Our supplier selection and onboarding procedure, described in detail below, includes due diligence relating to Modern Slavery issues and treatment of workers.

We are not currently aware of any allegations of Modern Slavery against 2Encapsulate or any of our key suppliers. If we were, we would investigate and consider taking action where appropriate (which may include reporting credible allegations to authorities).

  1. Risk Assessment

We conduct regular Modern Slavery risk assessments to help us to identify where the risk of Modern Slavery occurring in our operations and supply chains is highest.

In the past year, we conducted a risk assessment of our supply chain that took into account:

  • The risk profile of individual countries based on the Global Slavery Index;

  • The business services rendered by suppliers;

  • The presence of vulnerable demographic groups; and

  • News analysis and the insights of labor and human rights groups.

This assessment has guided our response and the risk controls that we implement.

  1. Policies

2Encapsulate has implemented the following policies to assist in the detection and prevention of Modern Slavery in our operations (collectively with this Statement, the “Anti-Slavery Policies”):

  • Business Conduct Statement - this articulates our zero-tolerance policy regarding Modern Slavery and sets out the actions and behavior expected of directors, officers and employees of 2Encapsulate when representing the business; and

  • Supplier Compliance Policy - our Supplier Compliance Policy expressly prohibits Modern Slavery.

Compliance with such policies is monitored via management oversight.

Any employee who breaches the Anti-Slavery Policies will face disciplinary action, which could result in dismissal.

  1. Supplier Due Diligence

2Encapsulate conducts due diligence on all new key suppliers during onboarding and on existing suppliers at regular intervals. This includes some or all of the following:

  • Assessing the risk of Modern Slavery, including based on the particular services being offered and/or the geographic location of the supplier.

  • Carrying out enhanced due diligence on higher risk suppliers (including asking questions regarding the measures they have in place to detect and prevent Modern Slavery and suggesting remedial action that may reduce the risk of Modern Slavery).

  • Auditing existing suppliers in areas relating to employee welfare, including health and safety standards, labor relations, and employee contracts.

If a direct supplier fails to meet 2Encapsulate’s strict requirements concerning Modern Slavery or efforts to remedy such issue, 2Encapsulate will consider appropriate corrective action. Depending on the circumstances, such action may include requiring the supplier to undergo training, or, in severe cases, termination of the business relationship.

Taking a risk-based approach, we include contractual provisions in our key supplier contracts that will help us to identify and mitigate Modern Slavery risks in our supply chains. These include requiring suppliers to attest that they will comply with all relevant laws. This will allow 2Encapsulate greater flexibility when engaging with suppliers and reduce the risk of saying something inaccurate in this Statement.

  1. Training

2Encapsulate encourages training courses for all employees and supplier contacts, which covers:

  1. The forms of Modern Slavery in which people can be held and exploited;

  2. The size of the problem and the risk to our organization;

  3. Red flag indicators of Modern Slavery;

  4. How employees can identify the signs of Modern Slavery, including unrealistically low prices and how employees should respond if they suspect Modern Slavery;

  5. How suppliers can escalate potential Modern Slavery issues to the relevant people within their own organization;

  6. What help is available for the victims of Modern Slavery;

  7. What terms and guidance should be provided to suppliers in relation to anti-Modern Slavery policies and controls; and

What steps 2Encapsulate will take if a supplier fails to implement anti-Modern Slavery policies or controls.

  1. Measuring Effectiveness

2Encapsulate has defined a set of key performance indicators to help gauge our effectiveness in combatting Modern Slavery in our organization and supply chain. These include:

  • How many employees have completed training?

  • How many suppliers have rolled out an awareness and training program in relation to Modern Slavery?

  • How many reports have been made by our employees that indicate their awareness of and sensitivity to Modern Slavery issues?

This Statement covers April 2025 to date and has been approved by the General Counsel on 8th September 2025.